PIPELINE

A fully integrated biotherapeutics company, Ikaria is heavily invested in the development of its late-stage pipeline and early-stage assets. We are uniquely positioned to move rapidly in order to bring these late-stage therapies to market in an efficient manner.

Please see our R&D and Partners pages for information on the efforts driving our product growth.

Last updated: May 2010